GlassScriptPhysician profile
Thomas Rockland
NPI 1215934633
$3,502.98
in general payments reported to CMS, 2019-2025
39 companies · $888 in 2025
The $888 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $165 · 2021: $523 · 2022: $539 · 2023: $451 · 2024: $746 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,085.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $569.88 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $253.12 | 2022-2024 | Intellis Adaptivestim |
| Astellas Pharma US INC | $231.16 | 2024-2025 | Veozah |
| Abbvie INC. | $220.25 | 2022-2025 | Ubrelvy, Qulipta |
| Abbott Laboratories | $203.93 | 2023-2024 | Cardiomems, Freestyle Libre 3, Mitraclip |
| Amgen INC. | $198.45 | 2021-2025 | Repatha, Otezla, Evenity |
| Boston Scientific Corporation | $178.80 | 2019-2023 | Watchman |
| Lilly USA, LLC | $149.11 | 2020-2025 | Zepbound, Jardiance, Mounjaro |
| Edwards Lifesciences Corporation | $130.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.66 | 2021 | |
| Exact Sciences Corporation | $114.39 | 2023-2025 | Cologuard Collection Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.46 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $99.14 | 2023-2025 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $84.28 | 2023-2024 | Quviviq |
| Kestra Medical Technology Services, INC. | $73.77 | 2025 | Assure Wcd |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rockland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.